Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Gynecol Oncol ; 44(2): 191-4, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1544598

RESUMEN

A report of a case of rapidly growing vulvar cancer associated with vulvar condylomas in a patient with HIV infection is given. This aggressive tumor resembles those epithelial tumors observed in women with iatrogenic immunosuppression and lymphoid neoplasia currently observed in HIV patients.


Asunto(s)
Infecciones por VIH/complicaciones , Infecciones Tumorales por Virus/complicaciones , Neoplasias de la Vulva/complicaciones , Adulto , Femenino , Infecciones por VIH/diagnóstico , Humanos , Terapia de Inmunosupresión , Infecciones Tumorales por Virus/diagnóstico , Neoplasias de la Vulva/diagnóstico
2.
Gynecol Oncol ; 70(1): 90-3, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9698481

RESUMEN

OBJECTIVE: The objective was to determine if maximal cytoreductive surgery could carry any benefit in pelvic and abdominal recurrent endometrial carcinoma. METHODS: Twenty women at their first large pelvic or abdominal recurrence from endometrial carcinoma were treated with maximal cytoreductive surgery. Women were classified as R1 (residual tumor) or R0 (no residual tumor) by tumor left at the end of surgery. Adjuvant postoperative therapy was undertaken upon clinical judgement. Progression-free, overall, and cancer-related survivals were analyzed with the product-limit method and compared with the log-rank test. The Cox regression model was used to study the variables involved in progression-free and overall survival. RESULTS: Complete macroscopic resection of tumor was feasible in 13 women (65%). R0 group women had a significant both progression-free (median reached at 9.1 months) and overall survival (median reached at 11.8 months) compared to R1 group women. There were 2 (10%) perioperative deaths. Eight women died of cancer, 5 in the R1 group and 3 in the R0 group. There were four intercurrent deaths in women still free from the disease. Local control of neoplasia was achieved in 84.6% of R0 women and their survival was affected mostly by distant recurrences or intercurrent deaths. Residual tumor at the end of surgery was the only significant variable to affect both progression-free and overall survival. CONCLUSION: Intensive surgery is a valid treatment option in women with large pelvic or abdominal recurrence from endometrial carcinoma. Tumor can be completely resected and local control of the disease can be achieved in most of the patients, although survival could be affected by distant recurrence and intercurrent deaths.


Asunto(s)
Carcinoma/secundario , Carcinoma/cirugía , Neoplasias Endometriales/cirugía , Recurrencia Local de Neoplasia/cirugía , Anciano , Carcinoma/mortalidad , Supervivencia sin Enfermedad , Neoplasias Endometriales/mortalidad , Neoplasias Endometriales/patología , Femenino , Humanos , Persona de Mediana Edad , Recurrencia Local de Neoplasia/mortalidad
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda